Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells

Stem Cells Translational Medicine

Volumn 6, Issue 11, 2017, Pages 1956-1962

  Kim, Jung Hyun ^a   Kurtz, Andreas ^b   Yuan, Bao Zhu ^c   Zeng, Fanyi ^d   Lomax, Geoff ^e   Loring, Jeanne F ^f   Crook, Jeremy ^g,h   Ju, Ji Hyeon ⁱ   Clarke, Laura ^j   Inamdar, Maneesha S ^k   Pera, Martin ^l   Firpo, Meri T ^m   Sheldon, Michael ⁿ   Rahman, Nafees ^o   O'Shea, Orla ^p   Pranke, Patricia ^q   Zhou, Qi ^r   Isasi, Rosario ^s   Rungsiwiwut, Ruttachuk ^t   Kawamata, Shin ^u   Oh, Steve ^v   Ludwig, Tenneille ^w   Masui, Tohru ^x   Novak, Thomas J ^y   Takahashi, Tsuneo ^z   Fujibuchi, Wataru ^aa   Koo, Soo Kyung ^a   Stacey, Glyn N ^p   more..

^a Korea National Institute of Health   (South Korea)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e California Institute of Regenerative Medicine Therapeutics Program   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF WOLLONGONG   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ The Catholic University of Korea   (South Korea)

^j EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^k JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^l JACKSON LABORATORY   (United States)

^m UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁿ RUTGERS UNIVERSITY   (United States)

^o UNIVERSITY OF TORONTO   (Canada)

^p NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^q FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^r INSTITUTE OF ZOOLOGY   (China)

^s UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^t CHULALONGKORN UNIVERSITY   (Thailand)

^u FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^v AGENCY FOR SCIENCE   (Singapore)

^w WiCell Research Institute   (United States)

^x KEIO UNIVERSITY   (Japan)

^y Cellular Dynamics International   (United States)

^z KYOTO UNIVERSITY   (Japan)

^aa KYOTO UNIVERSITY   (Japan)

more..

Author keywords

Data standardization; Human embryonic stem cell (hESC); Human pluripotent stem cells; Induced pluripotent stem cell (iPSC); Informed consents; Quality assurance; Quality control; Stem cell banking

Indexed keywords

CELL THERAPY; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; INDUCED PLURIPOTENT STEM CELL; INFORMED CONSENT; MEDICINE; PLANT SEED; QUALITY CONTROL; STANDARDIZATION; BIOBANK; CYTOLOGY; INTERNATIONAL COOPERATION; ORGANIZATION; ORGANIZATION AND MANAGEMENT; STANDARDS; STEM CELL RESEARCH;

BIOLOGICAL SPECIMEN BANKS; CONGRESSES AS TOPIC; HUMAN EMBRYONIC STEM CELLS; HUMANS; INTERNATIONAL COOPERATION; STEM CELL RESEARCH;

EID: 85032507617     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.1002/sctm.17-0144     Document Type: Conference Paper

References (17)

1. Crook JM, Hei D, Stacey G. The International Stem Cell Banking Initiative (ISCBI): Raising standards to bank on. In Vitro Cell Dev Biol Anim 2010;46:169–172.
2. Crook JM, Stacey GN. Setting quality standards for stem cell banking, research and translation: The international stem cell banking initiative. In: Ilic D, eds. Stem Cell Banking. London, UK: Springer International Publishing AG, 2014:3–9.
3. Stacey G. Stem cell banking: A global view. Methods Mol Biol 2017;1590:3–10.
4. International Stem Cell Banking I. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev 2009;5:301–314.
5. Andrews PW, Baker D, Benvinisty N et al. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med 2015;10(suppl 2):1–44.
6. Isasi R, Andrews PW, Baltz JM et al. Identifiability and privacy in pluripotent stem cell research. Cell Stem Cell 2014;14:427–430.
7. Luong MX, Auerbach J, Crook JM et al. A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell 2011;8:357–359.
8. Seltmann S, Lekschas F, Muller R et al. hPSCreg—the human pluripotent stem cell registry. Nucleic Acids Res 2016;44:D757–763.
9. Sakurai K, Kurtz A, Stacey G et al. First proposal of minimum information about a cellular assay for regenerative medicine. Stem Cells Translational Medicine 2016;5:1345–1361.
10. Kilpinen H, Goncalves A, Leha A et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 2017;546:370–375.
11. Barry J, Hyllner J, Stacey G et al. Setting up a haplobank: Issues and solutions. Curr Stem Cell Rep 2015;1:110–117.
12. International Stem Cell I, Amps K, Andrews PW et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29:1132–1144.
13. Nazareth EJ, Ostblom JE, Lucker PB et al. High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias. Nat Methods 2013;10:1225–1231.
14. Nazareth EJ, Rahman N, Yin T et al. A multi-lineage screen reveals mTORC1 Inhibition enhances human pluripotent stem cell mesendoderm and blood progenitor production. Stem Cell Reports 2016;6:679–691.
15. Zhang Z, Wang W. RNA-Skim: A rapid method for RNA-Seq quantification at transcript level. Bioinformatics 2014;30:i283–i292.
16. Venkatesan J, Lowe B, Anil S et al. Combination of nano-hydroxyapatite with stem cells for bone tissue engineering. J Nanosci Nanotechnol 2016;16:8881–8894.
17. th November 2015 Available from G Stacey, UK Stem Cell Bank at glyn.stacey@nibsc.org. Last accessed August 23, 2017.